Status:
RECRUITING
Body Mass Index (BMI) and Quality of Life (QoL) in Cancer Patients
Lead Sponsor:
University of Rome Tor Vergata
Collaborating Sponsors:
S.I.C.O.G. partners
Conditions:
Neoplasm Malignant
Body Weight
Eligibility:
All Genders
18+ years
Brief Summary
BMI is a simple and widely recorded variable that may capture obesity or cachexia in cancer patients. How BMI is associated to health-related quality of life (HR-QoL) in such patients is poorly invest...
Detailed Description
Health-related quality of life (HRQoL) might have varied association to body weight in patients with solid cancer\[1\]. On one hand low body weight may reflect cancer-related anorexia and weight loss...
Eligibility Criteria
Inclusion
- Histologically confirmed diagnosis of solid tumor
- Age \>18 years
- Signed informed consent
- Life expectancy \> 12 weeks
Exclusion
- Inability to fill out the EORTC QLQ-C30 questionnaire.
- Absence of a certain diagnosis of solid tumor (e.g. subjects on screening programs)
- Diagnosis of second malignancies that might bias results interpretation
Key Trial Info
Start Date :
January 15 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 15 2034
Estimated Enrollment :
1380 Patients enrolled
Trial Details
Trial ID
NCT03873064
Start Date
January 15 2019
End Date
January 15 2034
Last Update
February 2 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tor Vergata University Hospital
Rome, Italy, 00133